Table 1.
Hazard | Reproductive risk | Best practices to mitigate risk |
---|---|---|
Anesthetic gases | Spontaneous abortions20 and preterm birth21 | Install scavenging and ventilation systems6,20–26
Properly inspect and maintain anesthesia machines, breathing circuits, and waste-gas scavenging systems6,22,25,26
Perform a comprehensive maintenance inspection annually Train all workers in hazard awareness, prevention, and control of exposures to waste anesthetic gases25 Inform female veterinary personnel of the risks27–29 |
Carbon monoxide | Fetal anoxia leading to fetal death23 | Do not enter a poorly ventilated, artificially heated area where animals may be ill or dying, because of a potential for carbon monoxide exposure23 |
Antineoplastic drugs and other hazardous pharmaceuticals | Reduced fertility, fetal loss, spontaneous abortion, preterm birth, and low birth weight30–32 | Read and follow recommendations in the following publications:
Other prevention practices for handling antineoplastic and other hazardous pharmaceuticals include the following:
Practice institution-wide prevention strategies,37 develop written chemotherapy safety protocols,33 and communicate risk and prevention strategies to employees32,33 |
Ethylene oxide (gas sterilization) | Spontaneous abortion26 | Ethylene oxide gas sterilization procedures should be avoided in general veterinary practice because of the challenges involved with safe use26 If ethylene oxide is to be used, consult OSHA guidance documents39 and OSHA standards document 29 CFR 1910.1047,40 and observe the following:
|
Insecticides and other pesticides | Birth defects41 and spontaneous abortion29 | Consult safety data sheets for the compounds42,43 Use appropriate protective measures to prevent or minimize exposure42 Avoid extralabel use42 Be aware that pesticide concentrates that require dilution pose a higher risk of exposure Avoid using materials that may absorb the compound and release it later43 Inform female veterinary personnel of possible reproductive effects of pesticide exposure29,44 Use extreme caution and biological monitoring to regulate occupational exposure to organophosphates41,43 |
Prostaglandins and other reproductive hormones (eg, GnRH analog, human chorionic gonadotropin, estrogen, progester one, synthetic progestin, testosterone, and oxytocin) | Spontaneous abortion, fetal death (PGF2α and its analog), prolongation of pregnancy (synthetic progestin), disruption of menstrual cycle (GnRH analog, synthetic progestin), and increased or decreased uterine bleeding (synthetic progestin)23,45 |
Pregnant women should not handle or administer prostaglandin products23,45 Avoid direct skin contact by wearing impervious gloves during drug handling; wash hands immediately after removing gloves; adhere to manufacturers’ safety warnings45 When specific warnings and guidelines are not provided, follow NIOSH guidelines15–17 If contact with skin occurs, wash the affected area immediately and seek medical attention45 |
DHHS = US Department of Health and Human Services. GnRH = Gonadotropin-releasing hormone. PG = Prostaglandin.